Skip to main content

Table 3 Complete response rate according to compliance for treatment

From: Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma

 GNRI/sarcopenia riskP
High cachexia riskLow cachexia risk
CR in all patients33/71 (46.5)136/157 (86.6)<  0.001
CR in patients who completed treatment without DA17/22 (77.3)79/87 (90.8)0.132
CR in patients who completed treatment with DA ≥ 75%a11/16 (68.8)39/42 (92.9)0.030
CR in patients who completed treatment with DA < 75%b2/5 (40.0)15/16 (93.8)0.028
CR in patients who early discontinued treatment3/28 (10.7)3/12 (25.0)0.341
  1. aRelative dose intensity of cyclophosphamide and doxorubicin ≥75%
  2. bRelative dose intensity of cyclophosphamide and/or doxorubicin < 75%
  3. Abbreviations: GNRI Geriatric Nutritional Risk Index, CR complete response, DA dose adjustment